EUR 3.3
(6.63%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 34.91 Million EUR | -14.04% |
2022 | 40.62 Million EUR | -33.02% |
2021 | 60.64 Million EUR | 73.14% |
2020 | 35.02 Million EUR | 14602.01% |
2019 | 238.24 Thousand EUR | -4.58% |
2018 | 249.67 Thousand EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 FY | 34.91 Million EUR | -14.04% |
2023 Q2 | - EUR | -100.0% |
2022 Q4 | 40.62 Million EUR | -26.44% |
2022 Q2 | 55.22 Million EUR | -8.94% |
2022 FY | 40.62 Million EUR | -33.02% |
2021 Q4 | 60.64 Million EUR | 36.67% |
2021 FY | 60.64 Million EUR | 73.14% |
2021 Q2 | 44.37 Million EUR | 26.69% |
2020 Q2 | 23.28 Million EUR | 0.0% |
2020 Q4 | 35.02 Million EUR | 50.43% |
2020 FY | 35.02 Million EUR | 14602.01% |
2019 FY | 238.24 Thousand EUR | -4.58% |
2018 FY | 249.67 Thousand EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
MPH Health Care AG | 266.35 Million EUR | 86.89% |
Apontis Pharma AG | 57.5 Million EUR | 39.273% |
Dermapharm Holding SE | 2.18 Billion EUR | 98.401% |
Evotec SE | 2.29 Billion EUR | 98.481% |
MERCK Kommanditgesellschaft auf Aktien | 49.12 Billion EUR | 99.929% |
PharmaSGP Holding SE | 131.29 Million EUR | 73.406% |